EUVIMEDEUVIMED entdecken
Crossref

2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency

Alison Knopf

The Brown University Child & Adolescent Psychopharmacology Update · 2026-04 · 28 (4) · 7-7

DOI: 10.1002/cpu.31055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Brown University Child & Adolescent Psychopharmacology Update, online erschienen am 23.03.2026. Verfasst von Alison Knopf.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Knopf, A. (2026). 2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency. The Brown University Child & Adolescent Psychopharmacology Update, 28(4), 7-7. https://doi.org/10.1002/cpu.31055

Vancouver

Knopf A. 2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency. The Brown University Child & Adolescent Psychopharmacology Update. 2026;28(4):7-7. doi:10.1002/cpu.31055

BibTeX
@article{Knopf2026,
  author = {Knopf, Alison},
  title = {2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency},
  journal = {The Brown University Child & Adolescent Psychopharmacology Update},
  year = {2026},
  volume = {28},
  number = {4},
  pages = {7--7},
  doi = {10.1002/cpu.31055}
}
Kostenlos starten →